Author

C. Bertinetti

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:protein structure prediction· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Alonso de la Vega· 1 shared A. Monfort-Vengut· 1 shared A. Teijo· 1 shared B. Ortigosa· 1 shared C. Marugan· 1 shared G. de Carcer· 1 shared G. Moreno-Bueno· 1 shared M. Gonzalez· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Alonso de la Vega

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

TPX2 expression promotes sensitivity to dasatinib in breast cancer by activating the YAP transcriptional signaling.

C. Marugan, B. Ortigosa, N. Sanz-Gomez, A. Monfort-Vengut, C. Bertinetti, A. Teijo, M. Gonzalez, A. Alonso de la Vega, M. J. Lallena, G. Moreno-Bueno, G. de Carcer

The paper identifies TPX2 as a gene that increases breast cancer sensitivity to dasatinib by activating the YAP pathway, and shows TPX2 and YAP are biomarkers for poor prognosis and potential dasatinib therapy.

bioRxiv · Sep 4, 2023Cancer Biology